Donald L. Hagan, LLC Sorrento Therapeutics, Inc. Transaction History

Donald L. Hagan, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$0.74 - $1.83 $14,827 - $36,667	20,037 Added 13.4%	169,514 $0
Q3 2022 Oct 12, 2022	BUY	$1.51 - $2.88 $91,715 - $174,928	60,739 Added 68.45%	149,477 $235,000
Q2 2022 Jul 20, 2022	BUY	$1.24 - $2.33 $2,236 - $4,203	1,804 Added 2.08%	88,738 $178,000
Q1 2022 Apr 18, 2022	BUY	$2.0 - $4.9 $26,700 - $65,415	13,350 Added 18.14%	86,934 $203,000
Q4 2021 Jan 20, 2022	BUY	$4.65 - $7.23 $142,545 - $221,635	30,655 Added 71.41%	73,584 $342,000
Q3 2021 Oct 20, 2021	BUY	$7.41 - $10.99 $21,274 - $31,552	2,871 Added 7.17%	42,929 $328,000
Q2 2021 Jul 19, 2021	BUY	$6.35 - $10.0 $24,987 - $39,350	3,935 Added 10.89%	40,058 $388,000
Q1 2021 Apr 27, 2021	BUY	$7.03 - $16.51 $82,229 - $193,117	11,697 Added 47.89%	36,123 $299,000
Q4 2020 Jan 15, 2021	BUY	$5.76 - $11.95 $50,250 - $104,251	8,724 Added 55.56%	24,426 $167,000
Q3 2020 Oct 16, 2020	BUY	$6.17 - $18.82 $22,212 - $67,752	3,600 Added 29.75%	15,702 $175,000
Q2 2020 Aug 03, 2020	SELL	$1.73 - $6.76 $24,047 - $93,964	-13,900 Reduced 53.46%	12,102 $76,000
Q1 2020 Apr 17, 2020	BUY	$1.57 - $4.76 $7,696 - $23,333	4,902 Added 23.23%	26,002 $67,000
Q4 2019 Jan 24, 2020	BUY	$1.45 - $4.17 $30,595 - $87,987	21,100 New	21,100 $89,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

Stay updated on Donald L. Hagan, LLC with notifications on news.